Navigation Links
Personal Genome Diagnostics and MolecularMD Collaborate to Provide Advanced Genomic Testing Services to Cancer Drug Developers
Date:10/25/2013

BALTIMORE, Oct. 25, 2013 /PRNewswire/ -- Personal Genome Diagnostics Inc. (PGDx), today announced that it will collaborate with MolecularMD to market a suite of comprehensive personalized medicine services to oncology researchers and drug developers, adding PGDx's expertise in Next-Generation Sequencing (NGS)-based cancer biomarker discovery to MolecularMD's capabilities in the development, validation and global delivery of cancer companion diagnostics. The collaboration is designed to provide a unique specialized service to the pharmaceutical and biotechnology industry, seamlessly spanning the entire spectrum of genomic and clinical trial services used in new drug R&D and clinical development. Under the terms of the agreement, the two companies will co-market each other's services to their pharmaceutical and biotechnology customers.

PGDx provides advanced genome mapping services and analyses to oncology researchers, clinicians and patients. It employs cancer exome analysis, which enables comprehensive, reliable and unbiased genome-wide identification of cancer-related mutations. The company's proprietary methods for genome sequencing and analysis are complemented by its deep expertise in cancer genomics.

MolecularMD provides molecular diagnostics products and services to pharmaceutical and biotechnology drug developers. Its capabilities range from specialty molecular testing services performed in its CLIA-certified and CAP-accredited laboratory to development of companion diagnostics that support new drug registrations. It also provides NGS services for clinical trials, including standard and custom-designed panels that can profile gene alterations relevant to therapeutic response or resistance.

"PGDx focuses on unbiased NGS-based approaches that are most relevant in the early stages of drug discovery and development, which complements MolecularMD's capabilities in the development of companion diagnos
'/>"/>

SOURCE Personal Genome Diagnostics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cedars-Sinai Medical Center to Use Exosome Diagnostics Exosome RNA Biofluid Kits in Neo-Natal Setting and Cancer for Development of Personalized Medicine Diagnostics
2. 2013 SharpBrains Virtual Summit to Discuss Latest on Digital Brain Health, Brain Fitness, Personal Health
3. Sanguine BioSciences Signs Agreements with More than 200 Partners to Enable Efficient Personalized Medicine Research
4. Personalized Medicine Makes Its Way to Pets With Cancer: Morphogenesis and SEVO-Med Team up for a Canine Cancer Field Study, First of Its Kind, Side-Effect-Free Process to Treat Companion Animals
5. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
6. Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets
7. The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris
8. DuPont Tate & Lyle Bio Products Collaborates with RML Incorporated to Develop Bio-Based Solution for Personal Care Products
9. NYSCF scientists create personalized bone substitutes from skin cells
10. Lucintel’s Analysis of Growth Opportunities in Global Polymer Ingredients Used in Personal Care Industry: Market to Reach $3,495 Million by 2017
11. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... first time, scientists have discovered how to produce ultra-thin ... stiffness greater than that of today,s strongest nanotubes and ... team led by John V. Badding, a professor of ... the 21 September 2014 issue of the journal ... view, our discovery is intriguing because the threads we ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 ... urological and interventional radiology products and services, has ... subsidiary with Clinicon Corporation for its ... HealthTronics’ portfolio of minimally invasive, mobile, surgical technology—offering ... , Under the agreement, HealthTronics will make available ...
(Date:9/19/2014)... From crop yields to disease risks, the biological characteristics ... traits." Just as for heightthe textbook example of a ... are shaped by multiple genetic and environmental influences, making ... down such genes, geneticists typically mate two individuals that ... a small mouseand then study their descendents, looking for ...
(Date:9/19/2014)... Follow us on LinkedIn ... the world has attracted diverse players including academic ... The early years of nanotechnology development was dominated ... the high risks involved, which deterred private and ... evolving technology have been growing over the years, ...
Breaking Biology Technology:Smallest possible diamonds form ultra-thin nanothreads 2Smallest possible diamonds form ultra-thin nanothreads 3Smallest possible diamonds form ultra-thin nanothreads 4HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3Want to link genes to complex traits? Start with more diversity 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4
... ROCKVILLE, Md., Dec. 9 EntreMed, Inc.,(Nasdaq: ... for the treatment of cancer and inflammatory diseases, ... study of ENMD-2076 in refractory,multiple myeloma patients. The ... Melvin and Bren Simon Cancer Center, Indianapolis, ...
... selected as the most promising biotech start-up company at ... which uses a proprietary process to convert wastewater from ... animal feed, was given top honors out of 22 ... capitalists: one from the sponsoring Colorado law firm of ...
... XTL,Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: ... the failure of the Bicifadine Phase 2b,clinical trial. The ... of its workforce. The remaining employees will be,responsible ... into XTL, or,for assisting in the liquidation and/or disposition ...
Cached Biology Technology:EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 2EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 3EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5
(Date:9/19/2014)... A new study shows that legume plants regulate ... cytokininssignaling molecules that are transmitted through the plant ... the number of bacteria-holding nodules in the roots. ... the National Institute for Basic Biology, the Graduate ... Center for Sustainable Resource Science in Japan. ...
(Date:9/18/2014)... located deep in the primitive brainstem has revealed how ... Harvard School of Medicine and the University at Buffalo ... the second "sleep node" identified in the mammalian brain ... to produce deep sleep. , Published online in August ... fully half of all of the brain,s sleep-promoting activity ...
(Date:9/18/2014)... robotic system that can operate inside the bore of ... of a biomedical research partnership program at Brigham and ... if the robot, in conjunction with real-time MRI images, ... costly, and less discomforting for the patient. The novel ... therapies with greater precision. , Developed by a team ...
Breaking Biology News(10 mins):For legume plants, a new route from shoot to root 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5
... is available in French . Quebec ... Nova Scotia Agricultural College, have discovered what causes Christmas tree ... of Christmas trees in homes. The authors presented their findings ... . The researchers have identified a plant hormoneethyleneresponsible for ...
... California, San Diego developed an explanation for why some ... brains of people with Alzheimer,s disease. These insights, published ... 21, come from detailed models of brain energy metabolism ... San Diego Jacobs School of Engineering. The ...
... whales that sink down to the seafloor provide a ... Previous research suggested that such "whale falls" were homes ... sinking five whale carcasses in Monterey Canyon, researchers from ... most of the animals at these sites were not ...
Cached Biology News:Researchers discover a way to delay Christmas tree needle loss 2Metabolism models may explain why Alzheimer's disease kills some neuron types first 2Metabolism models may explain why Alzheimer's disease kills some neuron types first 3Fleshing out the life histories of dead whales 2Fleshing out the life histories of dead whales 3Fleshing out the life histories of dead whales 4
Sheep polyclonal to Staphylococcus DNase ( Abpromise for all tested applications). Antigen: Full length native protein (purified)....
Mouse anti-hepatitis delta virus Class: Antibody Product Group: Bacterial and Viral Antigen...
Allophycocyanin (APC) anti-human CD193 (CCR3, CKR3) 25 tests...
Mouse monoclonal [YLI-90] to Ly49I (Biotin) ( Abpromise for all tested applications)....
Biology Products: